Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
G., Ghigiarelli, J
A recent study found that patients overpaid $10.2 million for GLP-1 drugs in just the first quarter of 2025 due to overlooked cost-saving opportunities, highlighting the need for smarter prior authorization approaches
1 Introduction Osteosarcoma is an aggressive malignancy with high metastatic potential and stagnant survival outcomes due to inherent chemoresistance ( The convergence of nanotechnology and immunotherapy offers a promising translational strategy to overcome these barriers
Inflammation becomes chronic
US$ 23.96
US$ 20.79
US$ 24.24
US$ 22.43
US$ 20.99
US$ 22.01
US$ 21.23
